Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
24-month overall survival rate of 67 percent achieved with TALVEY® 0.8 mg/kg biweekly dosing in the Phase 1/2 MonumenTAL-1 study MADRID , June 14, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) a
Payout Powerhouses: 7 Dividend Stocks to Buy Now
02:23pm, Thursday, 13'th Jun 2024
Just like in arguably most sports, balance is everything. The same applies to dividend stocks to buy.
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:33am, Thursday, 13'th Jun 2024
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June
07:10am, Thursday, 13'th Jun 2024
Building a solid retirement portfolio to carry you through your golden years requires just a few key ingredients like income reliability, dividend growth and exceptional yield. That's because retireme
Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
04:38pm, Wednesday, 12'th Jun 2024
Johnson & Johnson (NYSE:JNJ ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 12, 2024 2:00 PM ET Company Participants Jennifer Taubert - Executive Vice President, Innovative Medicine
Talc Plaintiffs File Motion for Temporary Restraining Order to Limit Johnson & Johnson's Use of Bankruptcy Strategy
02:26pm, Wednesday, 12'th Jun 2024
TRENTON, N.J.--(BUSINESS WIRE)--A group of ovarian cancer victims has filed a motion in federal court seeking to halt Johnson & Johnson (NYSE:JNJ) and its subsidiaries from pursuing a new bankruptcy f
Cancer victims ask court to block J&J talc bankruptcy
01:40pm, Wednesday, 12'th Jun 2024
A group of cancer victims asked a federal judge to block Johnson & Johnson's proposed bankruptcy settlement of tens of thousands of lawsuits alleging the company's baby powder and other talc products
Johnson & Johnson to pay $700 million settlement over talc products linked to cancer
10:21am, Wednesday, 12'th Jun 2024
Johnson & Johnson has agreed to pay $700 million to settle an investigation by 42 U.S. states and Washington, D.C. into its marketing of baby powder and other talc-based products blamed for allegedly
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
09:15am, Wednesday, 12'th Jun 2024
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash
With A Similar Revenue Base Is Johnson & Johnson A Better Pick Despite The 30% Fall In Tesla Stock This Year?
09:00am, Wednesday, 12'th Jun 2024
We believe that the pharmaceuticals bellwether Johnson & Johnson (NYSE: JNJ) is currently a better pick over the auto giant Tesla (NASDAQ: TSLA). The decision to invest often comes down to finding the
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge
07:30am, Wednesday, 12'th Jun 2024
Artificial intelligence is forecast to drive an innovation bonanza in healthcare. This innovation boom is expected to increase the human lifespan dramatically.
2 Stocks You Can Safely Hold for the Long Haul
06:10am, Wednesday, 12'th Jun 2024
These two healthcare leaders have impressive track records of longevity and success. Both companies still have qualities that should allow them to deliver strong returns.
Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts
06:50pm, Tuesday, 11'th Jun 2024
Johnson & Johnson (JNJ) closed the most recent trading day at $146.76, moving -0.25% from the previous trading session.
7 Recession-Proof Stocks to Buy Now for Peace of Mind
02:49pm, Tuesday, 11'th Jun 2024
Maintaining stability and security in investment portfolios is vital in an adverse macroeconomic environment. For instance, the current higher-for-longer interest rate environment coupled with other v
Johnson & Johnson reaches $700 million talc settlement with US states
01:12pm, Tuesday, 11'th Jun 2024
Johnson & Johnson has agreed to pay $700 million to settle an investigation by 42 U.S. states and Washington, D.C. into its marketing of baby powder and other products that contained talc.
